Erika Hamilton: Happy to have partnered with OBR to help get the word out about the new recommendations for germline testing in bcsm
Erika Hamilton shared a post on LinkedIn:
“Happy to have partnered with OBR to help get the word out about the new recommendations for germline testing in bcsm.
I’m hopeful that broader more consistent testing will also help us reduce disparities in testing.”
Source: Erika Hamilton/LinkedIn
Erika Hamilton is a medical oncologist and the Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute (USA). In her role, Dr. Hamilton oversees the research program and clinical trial menu for gynecologic and breast cancer from a medical oncology perspective. Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee a ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee. She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.